Phase 2 HIV Infections Clinical Trials
9 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–9 of 9 trials
Recruiting
Phase 1Phase 2
CAR-T Cells for HIV Infection
HIV Infections
Steven Deeks18 enrolled2 locationsNCT04648046
Recruiting
Phase 2
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
HIV Infections
ViiV Healthcare150 enrolled62 locationsNCT07202546
Recruiting
Phase 2
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Cardiovascular DiseasesHIV InfectionsAtherosclerosis+1 more
Priscilla Hsue, MD121 enrolled3 locationsNCT05488431
Recruiting
Phase 2
Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT
Cardiovascular DiseasesHIV InfectionsDysbiosis+2 more
Vanderbilt University Medical Center250 enrolled1 locationNCT05288790
Recruiting
Phase 1Phase 2
The Tatelo Plus Study
HIV InfectionsHIV
National Institute of Allergy and Infectious Diseases (NIAID)41 enrolled2 locationsNCT06508749
Recruiting
Phase 2
HIV-1 Infected Patients, Phase II Trial, Dual Combination Doravirine/Raltegravir Open Label
HIV Infections
Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida150 enrolled1 locationNCT04513626
Recruiting
Phase 2
Imaging Immune Activation in HIV by PET-MR
HIV Infections
CellSight Technologies, Inc.30 enrolled1 locationNCT03684655
Recruiting
Phase 1Phase 2
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
HIV Infections
ViiV Healthcare20 enrolled8 locationsNCT05674656
Recruiting
Phase 2
AVX754 (nucleoside reverse transcriptase inhibitor) to treat drug resistant HIV
HIV Infections
Avexa Ltd60 enrolled1 locationACTRN12605000742673